Log In
Print
BCIQ
Print
Print this Print this
 

cyclosporine (Sandimmune)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionCyclosporine
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentMarketed
IndicationRenal transplant rejection
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today